UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Efficacité et tolérance du bimékizumab sur deux ans chez des patients atteints de psoriasis modéré : analyse des données groupées de cinq essais cliniques de phase 3/3b

Annales de Dermatologie et de Vénéréologie - FMC, 2022-11, Vol.2 (8), p.A336-A337

2022

Volltextzugriff (PDF)

Bimekizumab efficacy and safety in patients with moderate to severe plaque psoriasis: Two-year interim results from the open-label extension of the randomized BE RADIANT phase 3b trial

Journal of the American Academy of Dermatology, 2023-09, Vol.89 (3), p.486-495

2023

Volltextzugriff (PDF)

Maintenance of bimekizumab efficacy through 2 years in patients with moderate to severe plaque psoriasis: Pooled results from five phase 3/3b trials

Skin (Milwood, N.Y.), 2022-11, Vol.6 (6), p.s71

2022

Volltextzugriff (PDF)

DNA methylation profiling in MEN1-related pancreatic neuroendocrine tumors reveals a potential epigenetic target for treatment

European journal of endocrinology, 2018-09, Vol.179 (3), p.153-160

2018

Volltextzugriff (PDF)

Biochemical Testing in Patients with Neuroendocrine Tumors

Frontiers of hormone research, 2015-01, Vol.44, p.24

Granberg, Dan

2015

Volltextzugriff (PDF)

Drug therapy : octreotide

The New England journal of medicine, 1996-01, Vol.334 (4), p.246-254

1996

Volltextzugriff (PDF)

Epidemiology of Neuroendocrine Tumors

Frontiers of hormone research, 2015, Vol.44, p.1

2015

Volltextzugriff (PDF)

Somatostatin receptor: scintigraphy and radionuclide therapy

Digestion, 1996, Vol.57 Suppl 1 (1), p.57-61

1996

Volltextzugriff (PDF)

Molecular radiotherapy with somatostatin analogs for (neuro-)endocrine tumors

Journal of endocrinological investigation, 2005, Vol.28 (11 Suppl International), p.146-150

2005

Volltextzugriff (PDF)

Genetics and Epigenetics of Pancreatic Neuroendocrine Tumors and Pulmonary Carcinoids

Frontiers of hormone research, 2015, Vol.44, p.115

2015

Volltextzugriff (PDF)

Comparison of three techniques for adrenalectomy

British journal of surgery, 1997-05, Vol.84 (5), p.679-682

1997

Volltextzugriff (PDF)

Somatostatin receptor scintigraphy: Its value in tumor localization in patients with cushing's syndrome caused by ectopic corticotropin or corticotropin-releasing hormone secretion

The American journal of medicine, 1994-04, Vol.96 (4), p.305-312

1994

Volltextzugriff (PDF)

Risk Factors for Meningitis After Transsphenoidal Surgery

Clinical infectious diseases, 1997-10, Vol.25 (4), p.852-856

1997

Volltextzugriff (PDF)

Pituitary tumour localization in patients with Cushing's disease by magnetic resonance imaging. Is there a place for petrosal sinus sampling?

Clinical endocrinology (Oxford), 1994-01, Vol.40 (1), p.87-92

1994

Volltextzugriff (PDF)

A role of (labeled) somatostatin analogs in the differential diagnosis and treatment of Cushing's syndrome

The journal of clinical endocrinology and metabolism, 1994, Vol.78 (1), p.17-19

1994

Volltextzugriff (PDF)

Intraoperative nuclear guidance in benign hyperparathyroidism and parathyroid cancer

European Journal of Nuclear Medicine, 1997-03, Vol.24 (3), p.246-251

1997

Volltextzugriff (PDF)

Somatostatin analogue treatment of neuroendocrine tumours

Postgraduate Medical Journal, 1996-07, Vol.72 (849), p.403-408

1996

Volltextzugriff (PDF)

Renal clearance of the thyrotropin-releasing hormone-like peptide pyroglutamyl-glutamyl-prolineamide in humans

The journal of clinical endocrinology and metabolism, 1997-09, Vol.82 (9), p.3068-3073

1997

Volltextzugriff (PDF)

Scintigraphy and radionuclide therapy with [indium-111-labelled-diethyl triamine penta-acetic acid-D-Phe1]-octreotide

Italian journal of gastroenterology and hepatology, 1999-10, Vol.31 Suppl 2, p.S219

1999

Volltextzugriff (PDF)

A comparison between the diagnostic value of gonadotropins, α-subunit, and chromogranin-A and their response to thyrotropin-releasing hormone in clinically nonfunctioning, α-subunit-secreting, and gonadotroph pituitary adenomas

The journal of clinical endocrinology and metabolism, 1993-09, Vol.77 (3), p.784-789

1993

Volltextzugriff (PDF)

In vivo imaging of pituitary tumours using a radiolabelled dopamine D2 receptor radioligand

Clinical endocrinology (Oxford), 1996-12, Vol.45 (6), p.755-767

1996

Volltextzugriff (PDF)

IGFBP-3 is a poor parameter for assessment of clinical activity in acromegaly

Clinical endocrinology (Oxford), 1995-10, Vol.43 (4), p.501-505

1995

Volltextzugriff (PDF)

Somatostatin receptor scintigraphy in non-medullary thyroid cancer

Digestion, 1996, Vol.57 Suppl 1 (1), p.36-37

1996

Volltextzugriff (PDF)

High serum levels of the thyrotropin-releasing hormone-like peptide pyroglutamyl-glutamyl-prolineamide in patients with carcinoid tumors

The journal of clinical endocrinology and metabolism, 1996-08, Vol.81 (8), p.2816-2820

1996

Volltextzugriff (PDF)

Octreotide and Related Somatostatin Analogs in the Diagnosis and Treatment of Pituitary Disease and Somatostatin Receptor Scintigraphy

Frontiers in neuroendocrinology, 1993, Vol.14 (1), p.27-55

1993

Volltextzugriff (PDF)

1 – 25 von 43

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(40)
Mit Volltextzugriff
(26)

Publikationsform

Artikel
(41)
Buchkapitel
(2)

Sprache

Englisch
(42)
Französisch
(1)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Efficacité et tolérance du bimékizumab sur deux ans chez des patients atteints de psoriasis modéré : analyse des données groupées de cinq essais cliniques de phase 3/3b

Bimekizumab efficacy and safety in patients with moderate to severe plaque psoriasis: Two-year interim results from the open-label extension of the randomized BE RADIANT phase 3b trial

Maintenance of bimekizumab efficacy through 2 years in patients with moderate to severe plaque psoriasis: Pooled results from five phase 3/3b trials

DNA methylation profiling in MEN1-related pancreatic neuroendocrine tumors reveals a potential epigenetic target for treatment

Biochemical Testing in Patients with Neuroendocrine Tumors

Drug therapy : octreotide

Epidemiology of Neuroendocrine Tumors

Somatostatin receptor: scintigraphy and radionuclide therapy

Molecular radiotherapy with somatostatin analogs for (neuro-)endocrine tumors

Genetics and Epigenetics of Pancreatic Neuroendocrine Tumors and Pulmonary Carcinoids

Comparison of three techniques for adrenalectomy

Somatostatin receptor scintigraphy: Its value in tumor localization in patients with cushing's syndrome caused by ectopic corticotropin or corticotropin-releasing hormone secretion

Risk Factors for Meningitis After Transsphenoidal Surgery

Pituitary tumour localization in patients with Cushing's disease by magnetic resonance imaging. Is there a place for petrosal sinus sampling?

A role of (labeled) somatostatin analogs in the differential diagnosis and treatment of Cushing's syndrome

Intraoperative nuclear guidance in benign hyperparathyroidism and parathyroid cancer

Somatostatin analogue treatment of neuroendocrine tumours

Renal clearance of the thyrotropin-releasing hormone-like peptide pyroglutamyl-glutamyl-prolineamide in humans

Scintigraphy and radionuclide therapy with [indium-111-labelled-diethyl triamine penta-acetic acid-D-Phe1]-octreotide

A comparison between the diagnostic value of gonadotropins, α-subunit, and chromogranin-A and their response to thyrotropin-releasing hormone in clinically nonfunctioning, α-subunit-secreting, and gonadotroph pituitary adenomas

In vivo imaging of pituitary tumours using a radiolabelled dopamine D2 receptor radioligand

IGFBP-3 is a poor parameter for assessment of clinical activity in acromegaly

Somatostatin receptor scintigraphy in non-medullary thyroid cancer

High serum levels of the thyrotropin-releasing hormone-like peptide pyroglutamyl-glutamyl-prolineamide in patients with carcinoid tumors

Octreotide and Related Somatostatin Analogs in the Diagnosis and Treatment of Pituitary Disease and Somatostatin Receptor Scintigraphy

Suchergebnisse filtern